CGIM
TMO icon

Capital Group Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Capital Group Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.96M Sell
10,088
-2,711
-21% -$1.47M 0.85% 35
2025
Q4 		$7.42M Buy
12,799
+355
+3% +$201K 1.2% 19
2025
Q3 		$6.04M Sell
12,444
-15
-0.1% -$6.98K 1.01% 27
2025
Q2 		$5.05M Sell
12,459
-314
-2% -$131K 0.9% 33
2025
Q1 		$6.36M Buy
12,773
+2,854
+29% +$1.55M 1.3% 20
2024
Q4 		$5.16M Sell
9,919
-987
-9% -$543K 0.98% 27
2024
Q3 		$6.75M Buy
10,906
+72
+0.7% +$42.6K 1.36% 19
2024
Q2 		$5.99M Sell
10,834
-1,066
-9% -$611K 1.29% 19
2024
Q1 		$6.92M Buy
11,900
+1,794
+18% +$1.01M 1.24% 18
2023
Q4 		$5.36M Sell
10,106
-470
-4% -$227K 0.56% 66
2023
Q3 		$5.35M Hold
10,576
– – 0.35% 86
2023
Q2 		$5.52M Buy
10,576
+138
+1% +$74.5K 0.27% 85
2023
Q1 		$6.02M Sell
10,438
-2,127
-17% -$1.2M 0.32% 83
2022
Q4 		$6.92M Buy
+12,565
New +$6.66M 0.27% 88

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Group Investment Management's TMO Position: Q1 2026 in Review

Capital Group Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, selling an estimated $1.47M and leaving 10,088 shares worth $4.96M. The position accounts for 0.85% of the portfolio, ranked #35.

Capital Group Investment Management first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.42M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Capital Group Investment Management held 10,088 shares of Thermo Fisher Scientific worth $4.96M as of Q1 2026.
  • Capital Group Investment Management sold 2,711 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.47M.
  • Thermo Fisher Scientific made up 0.85% of Capital Group Investment Management's portfolio in Q1 2026, its #35 holding.
  • Capital Group Investment Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Capital Group Investment Management's Thermo Fisher Scientific position peaked at $7.42M in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Capital Group Investment Management's 13F filing for Q1 2026, filed 13 May 2026.